logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8895057 B1

PDFFull Text
Date of Patent:
Nov. 25, 2014

Filed:

Oct. 08, 2013

Escalating dosing regimen for effecting weight loss and treating obesity

Applicant:

Vivus, Inc., Mountain View, CA (US);

Inventors:

Thomas Najarian, Los Osos, CA (US);

Peter Y. Tam, Redwood City, CA (US);

Leland F. Wilson, Menlo Park, CA (US);

Assignee:

Vivus, Inc., Mountain View, CA (US);

Attorneys:

Cooley LLP

Ivor R. Elrifi

Matthew Pavao

Primary Examiner:

Hasan Ahmed

Int. Cl.
CPC ...
A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 31/00 (2006.01); A61K 31/357 (2006.01); A61K 31/7048 (2006.01); A61K 9/16 (2006.01); A61K 31/35 (2006.01); A61K 31/137 (2006.01); A61K 31/135 (2006.01);
U.S. Cl.
CPC ...
A61K 31/357 (2013.01); A61K 9/1679 (2013.01); A61K 9/5026 (2013.01); A61K 31/00 (2013.01); A61K 31/7048 (2013.01); A61K 9/5084 (2013.01); A61K 9/5047 (2013.01); A61K 9/167 (2013.01); A61K 31/35 (2013.01); A61K 31/137 (2013.01); A61K 31/135 (2013.01); A61K 9/4866 (2013.01); A61K 9/5073 (2013.01);
Abstract

The present invention is drawn to novel topiramate compositions as well as methods for effecting weight loss, e.g., in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se. The present invention features an escalating dosing regimen adapted for the administration of topiramate and optionally a sympathomimetic agent such as phentermine or bupropion, in the treatment of obesity and related conditions.

Find Patent Forward Citations

Najarian, Thomas. (2014). Escalating dosing regimen for effecting weight loss and treating obesity (U.S. Patent No. 8895057). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8895057

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…